MyndTec Inc. Completes Non-Brokered Private Placement

Not for distribution to U.S. news wire services or dissemination in the United States. Mississauga,...

MyndTec Inc. Announces Non-Brokered Private Placement

Mississauga, Ontario, November 9, 2022, – – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC),...

MyndTec Announces the North American Launch of its Innovative Foot Drop FES Device MyndStep™

MyndStep™ is designed to improve mobility by providing functional electrical stimulation (FES) treatment to patients...

MyndTec Announces Exclusive Supply and Distribution Agreement for Innovative Foot Drop FES Device MyndStep™ across the US and Canada

MyndStep™ is designed to provide functional electric stimulation (FES) treatment to patients suffering from foot...

MyndTec Announces Board Changes

William (Bill) Jackson, a well-rounded medical device and healthcare entrepreneur joins MyndTec’s Board of Directors...

MyndTec Announces Investor Relations Agreement with Venture North Capital

Mississauga, Ontario, May 3, 2022 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an...

Fourier Intelligence Inks Strategic Alliance Partnership with MyndTec Inc.

The award-winning Canadian MyndMove™ therapy from MyndTec. Inc joins SoftBankbacked rehab robotics leader Fourier Intelligence’s...

MyndTec Announces Resignation of Director

Mississauga, Ontario, March 8, 2022 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an...

MyndTec Receives FDA 510(k) Clearance for MyndMove 2.0, its Second Generation Neuromodulation Device, for Clinical and Home Use

Mississauga, Ontario, March 8, 2022 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an...

Ownership of Milos and Kathrin Popovic in MyndTec Inc.

Toronto, Canada – February 24, 2022 – MyndTec Inc. (MyndTec or Company) filed and received...